Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.

Journal of virology - 1 Sept 2015

van de Water Sandra G P, van Gennip René G P, Potgieter Christiaan A, Wright Isabel M, van Rijn Piet A

Abstract excerpt

UNLABELLED: African horse sickness virus (AHSV) is a virus species in the genus Orbivirus of the family Reoviridae. There are nine serotypes of AHSV showing different levels of cross neutralization. AHSV is transmitted by species of Culicoides biting midges and causes African horse sickness (AHS) in equids, with a mortality rate of up to 95% in naive horses. AHS has become a serious threat for countries outside...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Capsid Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cricetinae

Share to Horses

Share to Vaccines, Attenuated

Share to Vaccines, Subunit

Share to Viral Nonstructural Proteins

Share to Viral Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 26063433
DOI: 10.1128/JVI.01052-15
PMCID: PMC4524073

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.PMID 26063433Read ↗

Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All SerotypesSemantic proximity Read ↗

African Horse Sickness: A Review of Current Understanding and Vaccine DevelopmentSemantic proximity Read ↗

African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004-2014.Semantic proximity Read ↗

Recovery of African horse sickness virus from synthetic RNASemantic proximity Read ↗

Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine VectorSemantic proximity Read ↗

Structural Protein VP2 of African Horse Sickness Virus Is Not Essential for Virus Replication In Vitro.Semantic proximity Read ↗

Development of a live attenuated vaccine candidate for equid alphaherpesvirus 1 control: a step towards efficient protection.Semantic proximity Read ↗

Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV)Semantic proximity Read ↗

Highly efficient vaccines for Bluetongue virus and a related Orbivirus based on reverse geneticsSemantic proximity Read ↗

Avipoxviruses: infection biology and their use as vaccine vectorsSemantic proximity Read ↗

Developing virus-like particles (VLPs) and heterologous VLPs vaccines for epizootic hemorrhagic disease virus (EHDV) serotypesSemantic proximity Read ↗

A reverse genetics system of African horse sickness virus reveals existence of primary replicationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.